| EffRx, Inc. Signs Exclusive Patent License Agreement with Merck & Co., Inc. |
| Palm Beach County, FL, May 31, 2006 -- EffRx, Inc.
announced today that it has entered into a worldwide
exclusive license agreement with Merck & Co., Inc. granting
EffRx a license to a number of patents related to
effervescent technology in the bisphosphonate area.
Financial terms were not disclosed. |
| "We believe this agreement significantly increases EffRx's
protection for its effervescent bisphosphonate products and
future revenue stream," said Christer Rosén, Chairman & CEO
of EffRx, Inc. "It gives us a great deal of satisfaction to
know that we have been able to establish this agreement
with a company of Merck's caliber in such a significant
therapeutic area". |
About Bisphosphonates
Bisphosphonates are the leading treatment for osteoporosis,
the most prevalent bone disease in the U.S. that can lead to
bone loss and an increased risk of fractures. More than 10
million Americans over age 50 have osteoporosis and another
34 million have low bone mass. Osteoporosis is especially
common in women after menopause, but also occurs in older
men. Most often, it is due to an increase in the rate of
resorption, or breakdown, of bone tissue that is not matched
by the rate of bone formation. |
| The risk of having an osteoporosis-related
fracture increases with age. According to the U.S. Surgeon
General, osteoporosis is a national health threat. By
2020, half of all Americans over the age of 50 will be at
risk for fractures from osteoporosis or low bone mass. In
fact, it is estimated that half of all women over age 50
will have an osteoporosis-related fracture in their
remaining lifetime, with the risk of fracture increasing
with age. |
| International Osteoporosis Foundation
(IOF) states, fractures caused by osteoporosis in women
over 45 years of age are responsible for more days spent in
hospitals than most other diseases, including breast cancer
or heart attack. The IOF further noted that the lifetime
risk for a woman or man dying from hip fracture
complications is the same as for dying of breast or
prostate cancer respectively. |
About EffRx:
EffRx, Inc., a privately held company, is based in Palm
Beach County, Florida. EffRx develops innovative drug
delivery solutions, targeting therapeutic advantages and
increased compliance for established pharmaceutical products.
Key therapeutic areas include Osteoporosis, Oral Healthcare
and Pain Management. |
| For more information, please contact: |
Christer Rosén, EffRx, Inc. (+) 1-561-746-2125
info@effrx.com |
